WORLD
Amylyx Prices Newly Approved ALS Drug at $158,000 Per Year - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Amylyx prices newly approved ALS drug at $158,000 per year ...'
Amylyx prices newly approved ALS drug at $158,000 per year https://t.co/JKJEsMPgmz pic.twitter.com/n7dBvrVvXa— Reuters (@Reuters) October 1, 2022
(The above story first appeared on LatestLY on Oct 01, 2022 08:16 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
